Add-On Spironolactone for Persistent Proteinuria After Sodium-Glucose Cotransporter 2 Inhibitor Therapy in Patients With Diabetic Kidney Disease: A Retrospective Observational Study. [PDF]
Sugiyama S +8 more
europepmc +1 more source
Spironolactone and Fibrosis in Heart Failure Risk: Machine Learning Analysis of HOMAGE Trial Plasma Proteomics. [PDF]
Ravassa S +20 more
europepmc +1 more source
Kidney Effectiveness and Safety of Adding Spironolactone in Patients With Type 2 Diabetes Receiving Renin-Angiotensin System Inhibitors Therapy. [PDF]
Lin WR +7 more
europepmc +1 more source
A network pharmacology-guided multi-omics and spatial single-cell framework nominates WT1 as a spironolactone-linked immune biomarker in prostate cancer. [PDF]
Zhu Z, He X.
europepmc +1 more source
Beyond Isotretinoin: A Narrative Review of Emerging Systemic Therapies for Moderate-to-Severe Acne. [PDF]
Tommasino N +3 more
europepmc +1 more source
A Case of Estrogen Dermatitis Successfully Treated With Spironolactone. [PDF]
Singhal T, Olds H, Pourang A, Potts GA.
europepmc +1 more source
Dissecting the role of mineralocorticoid receptors in binge-like alcohol drinking in mice: Finerenone as a potential pharmacotherapy. [PDF]
Wilkinson CS +6 more
europepmc +1 more source
Differential cardiometabolic outcomes of leuprolide versus spironolactone in women with polycystic ovary syndrome. [PDF]
Goliger M +6 more
europepmc +1 more source
Factors Influencing the Efficacy of Low-Dose Spironolactone in Adults with Chronic Kidney Disease and Type 2 Diabetes: A post hoc Analysis. [PDF]
Takayama S +6 more
europepmc +1 more source
Plasma atrial natriuretic factor in patients with cirrhosis [PDF]
Arendt, Rainer M. +5 more
core

